Abstract
OBJECTIVES--To investigate whether interstitial collagenase (MMP-1) concentration in synovial fluid can be useful as a marker for disease activity in rheumatoid arthritis (RA), to determine the main route by which collagenase degrades the matrix of articular cartilage, and to investigate if an imbalance between metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMP) is responsible for the activity of MMPs in RA. METHODS--Collagenase concentrations were measured in synovial fluid and paired serum samples using a specific sandwich enzyme linked immunosorbent assay. Collagenase activities were also assayed in synovial fluid samples. Synovial tissues obtained from the same patient were examined by immunohistochemical staining and the numbers of cells expressing collagenase were counted. RESULTS--Collagenase concentrations in synovial fluid did not correlate with C reactive protein and collagenase levels in serum, but did correlate positively with the degree of synovial inflammation, and increased with increasing numbers of cells identified as expressing collagenase in synovial tissue. Collagenase activities did not correlate with TIMP-1 concentrations, but did correlate strongly with the ratios of collagenase concentration to TIMP-1 (r = 0.73). CONCLUSION--The collagenase concentration in synovial fluid cannot be used as a marker for systemic disease activity, but can be used as a marker for the degree of synovial inflammation in the joint from which the sample is aspirated. In advanced RA, most of the collagenase is probably produced in synovial lining cells and released into synovial fluid, where it degrades the matrix of articular cartilage. An imbalance between MMP and TIMP may be of importance in the degradation of extracellular matrix of articular cartilage in RA.
Full text
PDF





Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe S., Nagai Y. Evidence for the presence of a latent form of collagenase in human rheumatoid synovial fluid. J Biochem. 1972 May;71(5):919–922. doi: 10.1093/oxfordjournals.jbchem.a129846. [DOI] [PubMed] [Google Scholar]
- Abe S., Shinmei M., Nagai Y. Synovial collagenase and joint diseases: the significancy of latent collagenase with special reference to rheumatoid arthritis. J Biochem. 1973 May;73(5):1007–1011. doi: 10.1093/oxfordjournals.jbchem.a130154. [DOI] [PubMed] [Google Scholar]
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
- Cawston T. E., Galloway W. A., Mercer E., Murphy G., Reynolds J. J. Purification of rabbit bone inhibitor of collagenase. Biochem J. 1981 Apr 1;195(1):159–165. doi: 10.1042/bj1950159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cawston T. E., Murphy G., Mercer E., Galloway W. A., Hazleman B. L., Reynolds J. J. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J. 1983 May 1;211(2):313–318. doi: 10.1042/bj2110313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark I. M., Powell L. K., Ramsey S., Hazleman B. L., Cawston T. E. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993 Mar;36(3):372–379. doi: 10.1002/art.1780360313. [DOI] [PubMed] [Google Scholar]
- Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985 Dec 1;162(6):2163–2168. doi: 10.1084/jem.162.6.2163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dean D. D., Martel-Pelletier J., Pelletier J. P., Howell D. S., Woessner J. F., Jr Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989 Aug;84(2):678–685. doi: 10.1172/JCI114215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ehrlich M. G., Mankin H. J., Jones H., Wright R., Crispen C., Vigliani G. Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage. J Clin Invest. 1977 Feb;59(2):226–233. doi: 10.1172/JCI108632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Evanson J. M., Jeffrey J. J., Krane S. M. Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture. Science. 1967 Oct 27;158(3800):499–502. doi: 10.1126/science.158.3800.499. [DOI] [PubMed] [Google Scholar]
- Evanson J. M., Jeffrey J. J., Krane S. M. Studies on collagenase from rheumatoid synovium in tissue culture. J Clin Invest. 1968 Dec;47(12):2639–2651. doi: 10.1172/JCI105947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fell H. B., Jubb R. W. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum. 1977 Sep-Oct;20(7):1359–1371. doi: 10.1002/art.1780200710. [DOI] [PubMed] [Google Scholar]
- Firestein G. S., Paine M. M., Littman B. H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991 Sep;34(9):1094–1105. doi: 10.1002/art.1780340905. [DOI] [PubMed] [Google Scholar]
- Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A., Eisen A. Z. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem. 1986 May 15;261(14):6600–6605. [PubMed] [Google Scholar]
- Gravallese E. M., Darling J. M., Ladd A. L., Katz J. N., Glimcher L. H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum. 1991 Sep;34(9):1076–1084. doi: 10.1002/art.1780340903. [DOI] [PubMed] [Google Scholar]
- Harris E. D., Jr, DiBona D. R., Krane S. M. Collagenases in human synovial fluid. J Clin Invest. 1969 Nov;48(11):2104–2113. doi: 10.1172/JCI106177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hasty K. A., Reife R. A., Kang A. H., Stuart J. M. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 1990 Mar;33(3):388–397. doi: 10.1002/art.1780330312. [DOI] [PubMed] [Google Scholar]
- Kodama S., Iwata K., Iwata H., Yamashita K., Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods. 1990 Feb 20;127(1):103–108. doi: 10.1016/0022-1759(90)90345-v. [DOI] [PubMed] [Google Scholar]
- Kodama S., Yamashita K., Kishi J., Iwata K., Hayakawa T. A sandwich enzyme immunoassay for collagenase inhibitor using monoclonal antibodies. Matrix. 1989 Jan;9(1):1–6. doi: 10.1016/s0934-8832(89)80011-3. [DOI] [PubMed] [Google Scholar]
- Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990 Apr;6(4):121–125. doi: 10.1016/0168-9525(90)90126-q. [DOI] [PubMed] [Google Scholar]
- McCachren S. S., Greer P. K., Niedel J. E. Regulation of human synovial fibroblast collagenase messenger RNA by interleukin-1. Arthritis Rheum. 1989 Dec;32(12):1539–1545. doi: 10.1002/anr.1780321207. [DOI] [PubMed] [Google Scholar]
- McCachren S. S., Haynes B. F., Niedel J. E. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol. 1990 Jan;10(1):19–27. doi: 10.1007/BF00917494. [DOI] [PubMed] [Google Scholar]
- Mizel S. B., Dayer J. M., Krane S. M., Mergenhagen S. E. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A. 1981 Apr;78(4):2474–2477. doi: 10.1073/pnas.78.4.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy G., Cockett M. I., Stephens P. E., Smith B. J., Docherty A. J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J. 1987 Nov 15;248(1):265–268. doi: 10.1042/bj2480265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy G., Reynolds J. J., Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem. 1985 Mar 10;260(5):3079–3083. [PubMed] [Google Scholar]
- Nagase H., Jackson R. C., Brinckerhoff C. E., Vater C. A., Harris E. D., Jr A precursor form of latent collagenase produced in a cell-free system with mRNA from rabbit synovial cells. J Biol Chem. 1981 Dec 10;256(23):11951–11954. [PubMed] [Google Scholar]
- Okada Y., Gonoji Y., Nakanishi I., Nagase H., Hayakawa T. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(5):305–312. doi: 10.1007/BF02899418. [DOI] [PubMed] [Google Scholar]
- Postlethwaite A. E., Raghow R., Stricklin G. P., Poppleton H., Seyer J. M., Kang A. H. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol. 1988 Feb;106(2):311–318. doi: 10.1083/jcb.106.2.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rooney M., Whelan A., Feighery C., Bresnihan B. Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. Arthritis Rheum. 1989 Apr;32(4):361–369. doi: 10.1002/anr.1780320402. [DOI] [PubMed] [Google Scholar]
- Sakamoto S., Sakamoto M., Matsumoto A., Goldhaber P., Glimcher M. J. Latent collagenase from the culture medium of embryonic chick bones. FEBS Lett. 1978 Apr 1;88(1):53–58. doi: 10.1016/0014-5793(78)80605-x. [DOI] [PubMed] [Google Scholar]
- Sapolsky A. I., Keiser H., Howell D. S., Woessner J. F., Jr Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. J Clin Invest. 1976 Oct;58(4):1030–1041. doi: 10.1172/JCI108526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shinkai H., Nagai Y. A latent collagenase from embryonic human skin explants. J Biochem. 1977 May;81(5):1261–1268. [PubMed] [Google Scholar]
- Shinmei M., Masuda K., Kikuchi T., Shimomura Y., Okada Y. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol Suppl. 1991 Feb;27:89–91. [PubMed] [Google Scholar]
- Stricklin G. P., Bauer E. A., Jeffrey J. J., Eisen A. Z. Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry. 1977 Apr 19;16(8):1607–1615. doi: 10.1021/bi00627a013. [DOI] [PubMed] [Google Scholar]
- Van Wart H. E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578–5582. doi: 10.1073/pnas.87.14.5578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vater C. A., Mainardi C. L., Harris E. D., Jr Activation in vitro of rheumatoid synovial collagenase from cell cultures. J Clin Invest. 1978 Nov;62(5):987–992. doi: 10.1172/JCI109228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wize J. A latent collagenase from rheumatoid synovial fluid. Purification and partial characterization. Biochim Biophys Acta. 1980 Sep 9;615(1):199–207. doi: 10.1016/0005-2744(80)90023-6. [DOI] [PubMed] [Google Scholar]
- Woolley D. E., Crossley M. J., Evanson J. M. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum. 1977 Jul-Aug;20(6):1231–1239. doi: 10.1002/art.1780200612. [DOI] [PubMed] [Google Scholar]